Page last updated: 2024-09-05

lenalidomide and Liver Failure, Acute

lenalidomide has been researched along with Liver Failure, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Q; Gong, Z; Jiao, F; Lv, J; Pei, M; Shi, C; Wang, L; Wang, Y; Zhang, H1
Jain, P1

Reviews

1 review(s) available for lenalidomide and Liver Failure, Acute

ArticleYear
Lenalidomide-induced acute liver failure.
    Blood transfusion = Trasfusione del sangue, 2009, Volume: 7, Issue:4

    Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; Lenalidomide; Liver Failure, Acute; Male; Myelodysplastic Syndromes; Organophosphonates; Thalidomide

2009

Other Studies

1 other study(ies) available for lenalidomide and Liver Failure, Acute

ArticleYear
TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury.
    Cell proliferation, 2020, Volume: 53, Issue:6

    Topics: Acute Kidney Injury; Animals; Cell Differentiation; Glycyrrhizic Acid; HMGB1 Protein; Humans; Inflammation; Lenalidomide; Liver Failure, Acute; Macrophages; Male; Mice, Inbred C57BL; Polymorphism, Single Nucleotide; Pyroptosis; Signal Transduction; THP-1 Cells; Tumor Necrosis Factor-alpha

2020